Top 20 alecensa.com competitors & alternatives




alecensa.com
estimated website worth is

$

<%= websiteWorthResult.URL + " thumbnail" %>
Website worth calculated at 8/8/2020
Check alecensa.com website worth
alecensa.com thumbnail

[ALECENSA® (alectinib) and Information for Patients Find information for patients about treatment with ALECENSA® (alectinib). See full safety for more information.]


alecensa.com competitors and alternatives



Top 20 alecensa.com competitors and alternatives are ranked by similar search terms, traffic and worth.
alecensa.com's top 5 competitors are: lcfamerica.org with 0 daily traffic and 79,600 estimated worth, genentech-access.com with 100 daily traffic and 72,500 estimated worth, thesocialmedwork.com with 150 daily traffic and 50,900 estimated worth, tarceva.com with 0 daily traffic and 11,400 estimated worth, copayassistancenow.com with 0 daily traffic and 5,700 estimated worth.



lcfamerica.org lcfamerica.org
Lung Cancer Foundation of America: Research and Awareness
Lung Cancer Foundation of America mission is dedicated to improving survivorship by funding transformative lung cancer research. Learn how you can help.


Daily Traffic: 0 Website Worth: $ 79,600

genentech-access.com genentech-access.com
Genentech Access Solutions | Health Care Professionals
Explore the Genentech Access Program for support, financial assistance, and resources for eligible patients. Learn how we can help you access your medications smoothly.


Daily Traffic: 100 Website Worth: $ 72,500

thesocialmedwork.com thesocialmedwork.com
New Medicines Globally | Everyone.org
Everyone.org


Daily Traffic: 150 Website Worth: $ 50,900

tarceva.com tarceva.com
Tarceva® (erlotinib) for Advanced Non-Small Cell Lung Cancer (NSCLC) Treatment
Information about Tarceva® (erlotinib) tablets as maintenance treatment for advanced stage non-small cell lung cancer (NSCLC). Tarceva is prescribed for patients with advanced-stage non-small cell lung cancer (NSCLC) whose cancer has not spread or grown after initial treatment with certain types of chemotherapy. (Maintenance treatment) Tarceva is prescribed for patients with advanced-stage non-small cell lung cancer (NSCLC) whose cancer has spread or grown after receiving at least 1 chemotherapy regimen. (2nd-/3rd-line treatment) Tarceva is not meant to be used at the same time as certain types of chemotherapy for NSCLC. Important Safety Information Possible effects on the lungs There have been reports of serious adverse events involving the lungs in a small number of patients taking Tarceva. These events have included death in some patients. The medical name for these types of events is interstitial (in-tur-STISH-ul) lung disease-like events (or ILD-like events). Possible effects on the kidneys and liver Liver and/or kidney problems (including deaths) have been reported in some patients taking Tarceva. Let your healthcare provider (HCP) know if you have a history of liver or kidney disease. Possible effects on the stomach and intestines Some patients taking Tarceva have developed a hole in the lining of their stomach or intestines (including deaths). It may happen more in patients who are taking certain other medicines or who have had certain stomach or intestinal diseases. Possible effects on the skin Some patients taking Tarceva have developed serious skin conditions. Some patients have died from these conditions. Possible effects on the eye Some patients taking Tarceva have developed eye irritation and damage to the cornea. The cornea is the clear part of the eyeball that covers the colored part of the eye and the pupil. Other eye problems such as abnormal eyelash growth, dry eyes, or changes in eyesight have also been reported. Patients should


Daily Traffic: 0 Website Worth: $ 11,400

copayassistancenow.com copayassistancenow.com
Co-pay Card Program - Create a Profile | OCREVUS
Co-pay Card Program - Create a Profile | OCREVUS


Daily Traffic: 0 Website Worth: $ 5,700

indianpharmanetwork.co.in indianpharmanetwork.co.in
Pharmaceutical Products - Legitimate Healthcare Consultant And Facilitator In Delhi
Indian Pharma Network www.indianpharmanetwork.co.in is a comprehensive platform that connects pharmaceutical professionals, suppliers, manufacturers, and distributors across India.


Daily Traffic: 480 Website Worth: $ 4,600

formularywatch.com formularywatch.com
Formulary Watch
Formulary Watch


Daily Traffic: 0 Website Worth: $ 0

gazyva.com gazyva.com
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
Learn about GAZYVA® (obinutuzumab) for first-line, R/R follicular lymphoma & first-line CLL. See important safety including Boxed Warnings for more information.


Daily Traffic: 0 Website Worth: $ 0

thecureinternational.com thecureinternational.com
Pharmaceuticals Suppliers, Medicine Distributor & Drugs Wholesaler in India, Delhi
The Cure International is Worldwide Top Indian Branded and Generic Drugs, Pharmaceutical Products Suppliers & Wholesaler in Delhi India like Anti-Cancer Medicine, Hepatitis Medicine, HIV / AIDS Drugs and Antibiotics with Chronic Diseases Medicine and Erectile Dysfunction Drugs Distributor in Delhi.


Daily Traffic: 0 Website Worth: $ 0

xalkori.com xalkori.com
XALKORI® (crizotinib) For ALK+ or ROS1+ mNSCLC Treatment | Safety Info
Learn about Rx XALKORI® (crizotinib) for treatment of ALK+ or ROS1+ non-small cell lung cancer that has spread to other parts of the body. See risks & benefits.


Daily Traffic: 0 Website Worth: $ 0

roche.com.bd roche.com.bd
Home | Roche Bangladesh Limited
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Our personalized healthcare strategy aims at providing medicines that enable tangible improvements in the health, quality of life and survival of patients.


Daily Traffic: 0 Website Worth: $ 0

tirupatienterprises.net tirupatienterprises.net
Anti Cancer Medicines and Anti Cancer Drug Wholesaler | Tirupati Enterprises, Delhi
Tirupati Enterprises - Anti Cancer Medicines, Anti Cancer Drug & Pharmaceutical Injection Wholesaler from Delhi, India


Daily Traffic: 0 Website Worth: $ 0

golcmc.com golcmc.com
Lung Cancer Mutation Consortium | Lung Cancer Research Foundation
the Lung Cancer Mutation Consortium is an association of major cancer centers that conducts clinical trials designed to change the practice of thoracic oncology.


Daily Traffic: 0 Website Worth: $ 0

lungcancernewstoday.com lungcancernewstoday.com
Lung Cancer News Today - Lung Cancer News Today
No Description.


Daily Traffic: 0 Website Worth: $ 0

cancertreatments.co.nz cancertreatments.co.nz
Cancer Treatment: Know Your Options
If you or someone you love is living with cancer, or worried about surviving cancer, there may be a Roche cancer treatment suitable for them.


Daily Traffic: 0 Website Worth: $ 0

lungcancernetwork.com.au lungcancernetwork.com.au
Overview | Lung Foundation Australia
Overview | Lung Foundation Australia


Daily Traffic: 0 Website Worth: $ 0

racopay.com racopay.com
Co-pay Card Program - Create a Profile | OCREVUS
Co-pay Card Program - Create a Profile | OCREVUS


Daily Traffic: 0 Website Worth: $ 0

northerncanceralliance.nhs.uk northerncanceralliance.nhs.uk
home - northern cancer alliance northern cancer alliance
The Northern Cancer Alliance is a multi-agency collaborative of providers, commissioners and third sector organisations, working together to increase cancer survival across the North East and North Cumbria. We do this by reducing inequalities, improving outcomes for everyone affected by cancer and delivering the best possible patient experience. The Northern Cancer Alliance views patients and …


Daily Traffic: 0 Website Worth: $ 0

gilotrifhcp.com gilotrifhcp.com
EGFR M+ Metastatic NSCLC Treatment | GILOTRIF® (afatinib) tablets
Learn more about GILOTRIF®, a 1st line treatment for patients with metastatic NSCLC whose tumors have non-resistant EGFR mutations. See ISI and full PI.


Daily Traffic: 0 Website Worth: $ 0

zykadia.com zykadia.com
ALK+ Advanced NSCLC Treatment | ZYKADIA® (ceritinib)
Learn more about ZYKADIA® a first-line or second-line treatment option in advanced metastatic NSCLC. This website is intended for HCPs outside the US.


Daily Traffic: 0 Website Worth: $ 0


Share on Social Media


Similar sites like alecensa.com